Previous studies have shown that PRDX2 expression is associated with the development of different solid cancers, including colorectal cancer (51, 52), lung adenocarcinoma (53), cervical cancer (54), ovarian cancer (55), and gastric cancer (56). Here, PRDX2 is linked to ovarian cancer.